Verismo Therapeutics Presents Preclinical Data at AACR 2026 for SynKIR(TM)-310 KIR-CAR Indicating Superior Preclinical Activity in B Cell Malignancies and Early Clinical Efficacy

Preclinical data showed enhanced anti-tumor activity and reduced cytokine release compared to conventional single-chain CAR T approaches -- Early clinical case from CELESTIAL-301 trial, the ...

Positive Clinical Results from HyBryte(TM) Comparative Study Evaluating HyBryte(TM) Against Valchlor(R) in the Treatment of Cutaneous T-Cell Lymphoma Published in Oncology and ...

(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...